Evaluation of Radiosensitization and Cytokine Modulation by Differentially PEGylated Gold Nanoparticles in Glioblastoma Cells

Glioblastoma (GBM) is known as the most aggressive type of malignant brain tumour, with an extremely poor prognosis of approximately 12 months following standard-of-care treatment with surgical resection, radiotherapy (RT), and temozolomide treatment. Novel RT-drug combinations are urgently needed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Bríanna N., Duffy, Daniel, McInerney, Caitríona E., Hutchinson, Ashton, Dabaja, Inaya, Bazzi, Rana, Roux, Stéphane, Prise, Kevin M., Butterworth, Karl T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298353/
https://www.ncbi.nlm.nih.gov/pubmed/37373179
http://dx.doi.org/10.3390/ijms241210032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298353/
https://www.ncbi.nlm.nih.gov/pubmed/37373179
http://dx.doi.org/10.3390/ijms241210032

Ejemplares similares